These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 31486485)

  • 21. LncRNA TP73-AS1 promotes malignant progression of hepatoma by regulating microRNA-103.
    Ma CX; Gao WC; Tian L
    Eur Rev Med Pharmacol Sci; 2019 Jun; 23(11):4713-4722. PubMed ID: 31210297
    [TBL] [Abstract][Full Text] [Related]  

  • 22. LncRNA MINCR promotes the development of liver cancer by regulating microRNA-107/β-catenin.
    Li H; Yuan R; Wang H; Li C; Wei J
    J BUON; 2020; 25(2):972-980. PubMed ID: 32521894
    [TBL] [Abstract][Full Text] [Related]  

  • 23. LncRNA SNHG14 promotes proliferation of endometrial cancer through regulating microRNA-655-3p.
    Wang GF; Wen LN
    Eur Rev Med Pharmacol Sci; 2020 Oct; 24(20):10410-10418. PubMed ID: 33155197
    [TBL] [Abstract][Full Text] [Related]  

  • 24. LncRNA LACAT1 promotes proliferation of oral squamous cell carcinoma cells by inhibiting microRNA-4301.
    Wang J; Huo F; Wang XR; Xu YY
    Eur Rev Med Pharmacol Sci; 2019 Mar; 23(6):2427-2435. PubMed ID: 30964168
    [TBL] [Abstract][Full Text] [Related]  

  • 25. LncRNA GIHCG promotes development of ovarian cancer by regulating microRNA-429.
    Yao N; Yu L; Zhu B; Gan HY; Guo BQ
    Eur Rev Med Pharmacol Sci; 2018 Dec; 22(23):8127-8134. PubMed ID: 30556850
    [TBL] [Abstract][Full Text] [Related]  

  • 26. LncSNHG14 promotes the development and progression of bladder cancer by targeting miRNA-150-5p.
    Li J; Wang AS; Wang S; Wang CY; Xue S; Guan H; Li WY; Ma TT; Shan YX
    Eur Rev Med Pharmacol Sci; 2019 Feb; 23(3):1022-1029. PubMed ID: 30779068
    [TBL] [Abstract][Full Text] [Related]  

  • 27. LncRNA CALML3-AS1 promotes tumorigenesis of bladder cancer via regulating ZBTB2 by suppression of microRNA-4316.
    Wang F; Zu Y; Huang W; Chen H; Xie H; Yang Y
    Biochem Biophys Res Commun; 2018 Sep; 504(1):171-176. PubMed ID: 30177388
    [TBL] [Abstract][Full Text] [Related]  

  • 28. LncRNA SNHG20 promotes the development of laryngeal squamous cell carcinoma by regulating miR-140.
    Li Y; Xu J; Guo YN; Yang BB
    Eur Rev Med Pharmacol Sci; 2019 Apr; 23(8):3401-3409. PubMed ID: 31081112
    [TBL] [Abstract][Full Text] [Related]  

  • 29. LncRNA CRNDE promotes the development of Wilms' tumor by regulating microRNA-424.
    Cui WW; Sun YL; Chen C; Feng RR; Xu W; Meng JJ; Zhang K
    Eur Rev Med Pharmacol Sci; 2020 Feb; 24(3):1088-1097. PubMed ID: 32096178
    [TBL] [Abstract][Full Text] [Related]  

  • 30. LINC00978 promotes bladder cancer cell proliferation, migration and invasion by sponging miR‑4288.
    Wang W; Xu Z; Wang J; Chen R
    Mol Med Rep; 2019 Aug; 20(2):1866-1872. PubMed ID: 31257499
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mechanism of lncRNA DUXAP8 in promoting proliferation of bladder cancer cells by regulating PTEN.
    Lin MG; Hong YK; Zhang Y; Lin BB; He XJ
    Eur Rev Med Pharmacol Sci; 2018 Jun; 22(11):3370-3377. PubMed ID: 29917188
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Long noncoding RNA LINC00319 regulates ROMO1 expression and promotes bladder cancer progression via miR-4492/ROMO1 axis.
    Yang Y; Zhang F; Huang H; Xie Z; Huang W; Xie H; Wang F
    J Cell Physiol; 2020 Apr; 235(4):3768-3775. PubMed ID: 31608995
    [TBL] [Abstract][Full Text] [Related]  

  • 33. UPK1B promotes the invasion and metastasis of bladder cancer via regulating the Wnt/β-catenin pathway.
    Wang FH; Ma XJ; Xu D; Luo J
    Eur Rev Med Pharmacol Sci; 2018 Sep; 22(17):5471-5480. PubMed ID: 30229818
    [TBL] [Abstract][Full Text] [Related]  

  • 34. LncRNA SNHG15 promotes proliferation and migration of lung cancer via targeting microRNA-211-3p.
    Cui HX; Zhang MY; Liu K; Liu J; Zhang ZL; Fu L
    Eur Rev Med Pharmacol Sci; 2018 Oct; 22(20):6838-6844. PubMed ID: 30402848
    [TBL] [Abstract][Full Text] [Related]  

  • 35. LncSNHG16 promotes proliferation and migration of osteosarcoma cells by targeting microRNA-146a-5p.
    Zheng SN; Ge DW; Tang J; Yang J; Yan JW; Qiu JJ; Yin ZW; Ni Y; Zhao L; Chen X; Yang L
    Eur Rev Med Pharmacol Sci; 2019 Jan; 23(1):96-104. PubMed ID: 30657551
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mechanism of LncRNA FOXC2-AC1 promoting lung cancer metastasis by regulating miR-107.
    Wu XF; Lu JT; Chen W; Wang N; Meng JC; Zhou YH
    Eur Rev Med Pharmacol Sci; 2019 Jan; 23(2):690-698. PubMed ID: 30720176
    [TBL] [Abstract][Full Text] [Related]  

  • 37. ELK1/lncRNA-SNHG7/miR-2682-5p feedback loop enhances bladder cancer cell growth.
    Wang W; Chen S; Song X; Gui J; Li Y; Li M
    Life Sci; 2020 Dec; 262():118386. PubMed ID: 32898531
    [TBL] [Abstract][Full Text] [Related]  

  • 38. LncRNA TRERNA1 promotes malignant progression of NSCLC through targeting FOXL1.
    Luo DB; Lv HB; Sun XH; Wang Y; Chu JH; Salai AL
    Eur Rev Med Pharmacol Sci; 2020 Feb; 24(3):1233-1242. PubMed ID: 32096153
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Long noncoding RNA MAGI2-AS3 regulates CCDC19 expression by sponging miR-15b-5p and suppresses bladder cancer progression.
    Wang F; Zu Y; Zhu S; Yang Y; Huang W; Xie H; Li G
    Biochem Biophys Res Commun; 2018 Dec; 507(1-4):231-235. PubMed ID: 30442369
    [TBL] [Abstract][Full Text] [Related]  

  • 40. HOXA10 promotes the development of bladder cancer through regulating FOSL1.
    Cui YP; Xie M; Pan WX; Zhang ZY; Li WF
    Eur Rev Med Pharmacol Sci; 2020 Mar; 24(6):2945-2954. PubMed ID: 32271412
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.